Deferasirox (the active ingredient)Inactive ingredients (vary by formulation – check product packaging for specifics)
Treatment of chronic iron overload due to transfusiondependent thalassemia
Treatment of chronic iron overload due to other causes such as hereditary hemochromatosis in patients not responding to phlebotomy
Ferasiro 180mg Tablet (Deferasirox) is an oral iron chelator. It works by binding to iron in the body and promoting its excretion in the urine and feces, thereby reducing the amount of iron stored in organs and tissues.
Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children. Discard any unused medication according to your pharmacist's or doctor's instructions.
Dosage is determined by the physician based on individual needs and iron overload levels.
Usually administered orally once daily, with or without food.
Do not crush or chew tablets; swallow whole with plenty of water.
Increased liver enzymes (may require liver function monitoring)
Nausea
Vomiting
Diarrhea
Abdominal pain
Rash
Headache
Kidney problems (monitor creatinine levels)
May increase the risk of liver damage; discuss alcohol intake with your doctor.
May cause dizziness or fatigue; avoid driving or operating machinery if affected.
Use only if the benefits clearly outweigh the potential risks; discuss with your doctor.
Dosage is adjusted based on weight and age; must be under strict medical supervision.
Renal impairment may necessitate dosage adjustment; regular monitoring of kidney function is essential.
Liver function should be monitored regularly as deferasirox can affect the liver; discontinuation might be necessary if liver issues arise.
Consult your physician or pharmacist for complete prescribing information.
Package insert provided with the medication.
